Why do some blood stem cells go rogue? Study finds a key

ORLANDO, Fla. — Lengthy earlier than leukemia varieties, sufferers typically have a inhabitants of blood or hematopoietic stem cells, all copies of each other that appear completely wholesome apart from harboring key mutations typically additionally present in malignant cells. Hematologists name this CHIP — clonal hematopoiesis of indeterminate potential — as a result of these cells progress into most cancers in about 1% of sufferers annually.

Now, hematologists could have considered one of their first home windows into methods to forestall that. A brand new research, offered Monday right here on the assembly of the American Affiliation of Most cancers Analysis, affords a approach to discover mutations that drive CHIP and, presumably, a goal that researchers may use to eradicate the clones earlier than they’ve an opportunity to trigger extra critical situations. However the work, as different consultants identified, is a good distance from being an precise therapeutic.